ABC | Volume 112, Nº2, Fevereiro 2019

Artigo Original Dippe Jr. Et al Estudo de perfusão miocárdica em obesos sem DCI conhecida Arq Bras Cardiol. 2019; 112(2):121-128 14. Hirko KA, Kantor ED, Cohen SS, Blot WJ, Stampfer MJ, Signorello LB. Body mass index in young adulthood, obesity trajectory, and prematuremortality. Am J Epidemiol . 2015;182(5):441-50. 15. International Diabetes Federation (IDF). IDF Diabetes Atlas. 8th ed. 2017. [citado 2018 out 30]. Disponível em: http://www.diabetesatlas.org/. 16. Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taillefer R, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA. 2009;301(15):1547-55. 17. HermanWH,ZimmetP.Type2diabetes:anepidemicglobalrequiringglobal attention and urgent action. Diabetes Care. 2012;35(5):943-4. 18. Shaw LJ, Butler J. Targeting priority populations to reduce disparities in cardiovascular care: health equity for all. J Am Coll Cardiol. 2014;64(4):346-8. 19. DaviglusML, TalaveraGA, Avilés-SantaML, AllisonM, Cai J, Criqui MH, et al. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the Unites States. JAMA. 2012;308(17):1775-84. 20. HenzlovaMJ, Duvall WL, Einstein AJ, TravinMI, VerberneHJ. ASNC imaging guidelines for SPECT nuclear cardiology procedures: stress, protocols, and tracers. J Nucl Cardiol. 2016;23(3):606-39. 21. Zaret B, Beller G. Clinical nuclear cardiology: state of the art and future directions. 4th ed. Philadelphia: Mosby; 2010. 22. Gualandro DM, Yu PC, Caramelli B, Marques AC, Calderaro D, Fornari LS, et al.,Sociedade Brasileira de Cardiologia. 3ª Diretriz de avaliação cardiovascular perioperatória da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol. 2017;109(3 Suppl 1):1-104. 23. Schinkel AF, Bax JJ, Geleijnse ML, Boersma E, Elhendy A, Roelandt JR, et al. Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography? Eur Heart J. 2003;24(9):789-800. 24. Lim SP, Arasaratnam P, Chow BJ, Beanlands RS, Hessian RC. Obesity and the challenges of noninvasive imaging for the detection of coronary artery disease. Can J Cardiol. 2015:31(2):223-6. 25. Duvall WL, Croft LB, Corriel JS, Einstein AJ, Fisher JE, Haynes PS, et al. SPECT myocardial perfusion imaging in morbidly obese patients: image quality, hemodynamic response to pharmacologic stress, and diagnostic and prognostic value. J Nucl Cardiol. 2006;13(2):202-9. 26. Mieres JH, Shaw LJ, Arai A, Budoff MJ, Flamm SD, Hundley WG, et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the cardiac imaging committee,councilonclinicalcardiology,andthecardiovascular imagingand interventioncommittee,counciloncardiovascularradiologyand intervention, American Heart Association. Circulation. 2005;111(5):682-96. 27. Cerci MS, Cerci JJ, Cerci RJ, Pereira Neto CC, Trindade E, Delbeke D, et al. Myocardial perfusion imaging is a strong predictor of death inwomen. JACC Cardiovasc Imaging. 2011;4(8):880-8. 28. HendelRC,BermanDS,DiCarliMF,HeidenreichPA,HenkinRE,PellikkaPA,et al.ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM2009appropriateusecriteria for cardiac radionuclide imaging: a report of the american college of cardiology foundation appropriate use criteria task force, the American Society of Nuclear Cardiology,theAmericanCollegeofRadiology,theAmericanHeartAssociation, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, andtheSocietyofNuclearMedicine.JAmCollCardiol.2009 ; 53(23):2201-29. 29. Fiechter M, Gebhard C, Fuchs TA, Ghadri JR, Stehli J, Kazakauskaite E, et al. Cadmium-zinc-telluride myocardial perfusion imaging in obese patients. J Nucl Med . 2012;53(9):1401-6. 30. BermanDS,KangX,NishinaH,SlomkaPJ,ShawLJ,HayesSW,etal.Diagnostic accuracy of gated Tc-99m sestamibi stress myocardial perfusion SPECT with combined supine and prone acquisitions to detect coronary artery disease in obese and nonobese patients. J Nucl Cardiol . 2006;13(2):191-201. 31. Aggarwal NR, Drozdova A, Askew JW 3rd, Kemp BJ, Chareonthaitawee P. Feasibility and diagnostic accuracy of exercise treadmill nitrogen-13 ammonia PET myocardial perfusion imaging of obese patients. J Nucl Cardiol. 2015;22(6):1273-80. 32. Chow BJ, Dorbala S, Di Carli MF, Merhige ME, Williams BA, Veledar E, et al. Prognostic value of PET myocardial perfusion imaging in obese patients. JACC Cardiovasc Imaging. 2014;7(3):278-87. Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 128